News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
224,431 Results
Type
Article (5009)
Company Profile (17)
Press Release (219405)
Section
Business (82262)
Career Advice (461)
Deals (15053)
Drug Delivery (8)
Drug Development (19067)
Employer Resources (30)
FDA (3679)
Job Trends (3902)
News (120187)
Policy (7504)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (292)
Adcomms (3)
Allergies (9)
Alliances (14757)
ALS (17)
Alzheimer's disease (239)
Antibody-drug conjugate (ADC) (9)
Approvals (3692)
Artificial intelligence (36)
Autoimmune disease (2)
Automation (2)
Bankruptcy (97)
Best Places to Work (2863)
Biosimilars (10)
Biotechnology (21)
Bladder cancer (7)
Brain cancer (7)
Breast cancer (44)
Cancer (396)
Cardiovascular disease (19)
Career advice (391)
Career pathing (2)
CAR-T (29)
Cell therapy (97)
Cervical cancer (2)
Clinical research (15960)
Collaboration (152)
Compensation (138)
Complete response letters (2)
COVID-19 (303)
CRISPR (7)
C-suite (83)
Cystic fibrosis (15)
Data (448)
Depression (5)
Diabetes (36)
Diagnostics (2032)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (9)
Earnings (40564)
Editorial (1)
Employer branding (6)
Employer resources (31)
Events (37591)
Executive appointments (274)
FDA (3893)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (168)
Gene editing (15)
Generative AI (2)
Gene therapy (43)
GLP-1 (102)
Government (407)
Guidances (16)
Healthcare (5033)
Huntington's disease (1)
IgA nephropathy (2)
Immunology and inflammation (12)
Indications (5)
Infectious disease (317)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (14)
Interviews (53)
IPO (7814)
IRA (3)
Job creations (1121)
Job search strategy (360)
Kidney cancer (6)
Labor market (4)
Layoffs (99)
Leadership (4)
Legal (2333)
Liver cancer (17)
Lung cancer (43)
Lymphoma (25)
Management (10)
Manufacturing (46)
MASH (24)
Medical device (3870)
Medtech (3871)
Mergers & acquisitions (7420)
Metabolic disorders (108)
Multiple sclerosis (5)
NASH (6)
Neurodegenerative disease (7)
Neuropsychiatric disorders (1)
Neuroscience (319)
NextGen: Class of 2025 (1674)
Non-profit (727)
Northern California (822)
Now hiring (2)
Obesity (50)
Opinion (30)
Ovarian cancer (15)
Pain (12)
Pancreatic cancer (13)
Parkinson's disease (20)
Partnered (4)
Patents (20)
Patient recruitment (25)
Peanut (4)
People (24525)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4760)
Phase II (6931)
Phase III (5518)
Pipeline (428)
Policy (4)
Postmarket research (625)
Preclinical (1852)
Press Release (66)
Prostate cancer (26)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (62)
Real estate (1873)
Recruiting (8)
Regulatory (5076)
Reports (13)
Research institute (300)
Resumes & cover letters (68)
Rett syndrome (2)
Schizophrenia (19)
Series A (25)
Series B (21)
Sickle cell disease (7)
Southern California (626)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (3)
Startups (1007)
Stomach cancer (1)
Supply chain (10)
United States (6370)
Vaccines (33)
Venture capitalists (2)
Webinars (4)
Weight loss (19)
Women's health (1)
Date
Today (45)
Last 7 days (179)
Last 30 days (949)
Last 365 days (10394)
2025 (2087)
2024 (11036)
2023 (13203)
2022 (18676)
2021 (19686)
2020 (18241)
2019 (13209)
2018 (10212)
2017 (10013)
2016 (9166)
2015 (12131)
2014 (9590)
2013 (7719)
2012 (8333)
2011 (8802)
2010 (8650)
Location
Africa (183)
Alabama (13)
Alaska (2)
Arizona (55)
Arkansas (1)
Asia (11409)
Australia (1595)
California (1729)
Canada (646)
China (57)
Colorado (72)
Connecticut (89)
Delaware (27)
Europe (24390)
Florida (239)
Georgia (31)
Idaho (23)
Illinois (106)
India (4)
Indiana (58)
Japan (61)
Kansas (24)
Kentucky (10)
Louisiana (5)
Maine (38)
Maryland (210)
Massachusetts (1400)
Michigan (82)
Minnesota (130)
Mississippi (1)
Missouri (21)
Montana (16)
Nebraska (12)
Nevada (21)
New Hampshire (15)
New Jersey (513)
New Mexico (5)
New York (435)
North Carolina (302)
North Dakota (2)
Northern California (822)
Ohio (50)
Oklahoma (4)
Oregon (3)
Pennsylvania (313)
Rhode Island (11)
South America (275)
South Carolina (4)
Southern California (626)
Tennessee (32)
Texas (202)
Utah (55)
Virginia (38)
Washington D.C. (8)
Washington State (153)
West Virginia (2)
Wisconsin (19)
224,431 Results for "cordis corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cordis Announces Positive 24-Month Results from Superficial Femoral Artery Study, Confirming Sustained Benefits of SELUTION SLR™ (sustained limus release) Drug-Eluting Balloon in Complex Patients
Cordis, a global leader in the development and manufacturing of interventional cardiovascular and endovascular technology, today announces positive 24-month results from the SELUTION SFA Japan Trial.
June 18, 2024
·
3 min read
BioMidwest
Cordis Announces Scott Drake as Chief Executive Officer
Cordis announced that its Board of Directors has appointed Scott Drake as Chief Executive Officer effective immediately.
November 6, 2023
·
2 min read
Deals
Cordis Announces the Completed Acquisition of MedAlliance
Cordis, a worldwide leader in the development and manufacturing of interventional cardiovascular and endovascular technology, announced that it has completed the acquisition of MedAlliance, a Switzerland-based developer of drug-eluting balloon technology.
October 2, 2023
·
3 min read
BioMidwest
Cordis issues statement on the CMS announcement to expand coverage of carotid stenting
Cordis, a worldwide leader in the development and manufacturing of interventional cardiovascular and endovascular technology, strongly supports the decision made by the Centers for Medicare & Medicaid Services to expand coverage of carotid artery stenting cms.gov.
October 16, 2023
·
2 min read
Cordis announces the completion of patient enrollment in SELUTION SLR™ SUCCESS PTA Study
Cordis has announced completion of patient enrollment in SUCCESS PTA, its large post-market study with the SELUTION SLR™ Drug-Eluting Balloon (DEB) for the treatment of patients with peripheral artery disease (PAD).
October 24, 2023
·
4 min read
News
Cordis receives FDA approval for MYNX CONTROL™ VENOUS Vascular Closure Device
July 9, 2024
·
2 min read
Press Releases
De Motu Cordis (DMC) Applauds ARS Pharma’s FDA Approval of Neffy®, Expanding Patient Options to Needle-Free Epinephrine Delivery and Inspiring Confidence in Our Own Development Efforts
August 16, 2024
·
3 min read
Cordis Announces Start of Enrollment in RADIANCY Clinical Study in Europe
Cordis, a global leader in cardiovascular technologies, today announced the start of the RADIANCY pre-market clinical study in Europe.
July 14, 2022
·
5 min read
BioMidwest
Cordis Names Bryan Loo President of Asia-Pacific Region
Cordis, a global leader in cardiovascular technologies, announced that Bryan Loo will assume the role of President of the Asia-Pacific region effective July 18, 2022.
July 8, 2022
·
2 min read
Biotech Beach
Cordis-X Makes Strategic Investment in Adient Medical, Developer of First Fully Absorbable Inferior Vena Cava (IVC) Filter
Cordis-X today announced an $11.5 million Series F investment in Adient Medical, maker of a next-generation absorbable inferior vena cava (IVC) filter that provides protection against pulmonary embolisms (PE).
June 14, 2022
·
4 min read
1 of 22,444
Next
